A. Marku
University of Milan
7 Papers
1 Citations
A. Marku is an academic researcher from University of Milan. The author has contributed to research in topics: Chemistry & LRRK2. The author has an hindex of 3, co-authored 5 publications.
Chat about Author
Papers
Iron Metabolism in Pancreatic Beta-Cell Function and Dysfunction.
TL;DR: In this paper, the authors provide insights into the mechanisms responsible for iron homeostasis in pancreatic beta-cells, describing how alteration of these processes has been related to beta-cell damage and failure.
Verbascoside Protects Pancreatic β-Cells against ER-Stress.
A. Galli,P. Marciani,A. Marku,Silvia Ghislanzoni,Federico Bertuzzi,Raffaella Rossi,Alessia Di Giancamillo,Michela Castagna,Carla Perego +8 more
TL;DR: The studies provide the evidence that verbascoside boosts the ability of β-cells to cope with ER-stress, an important contributor ofβ-cell dysfunction and failure in diabetic conditions and support the therapeutic potential of verbASCoside in diabetes.
37
Proteomic Analysis Reveals a Mitochondrial Remodeling of βTC3 Cells in Response to Nanotopography
Elisa Maffioli,A. Galli,Simona Nonnis,A. Marku,Armando Negri,Claudio Piazzoni,Paolo Milani,Cristina Lenardi,Carla Perego,Gabriella Tedeschi +9 more
TL;DR: The results suggest that, in βTC3 cells, mitochondria are perturbed by the nanotopography and activate a program involving metabolism modification and modulation of their interplay with other organelles.
Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson's disease
Ludovica Iovino,Veronica Giusti,Francesca Pischedda,Elena Giusto,Nicoletta Plotegher,Antonella Marte,Ilaria Battisti,Angela Di Iacovo,A. Marku,Giovanni Piccoli,Rina Bandopadhyay,Carla Perego,Tiziana Bonifacino,Giambattista Bonanno,Cristina Roseti,Elena Bossi,Giorgio Arrigoni,Luigi Bubacco,Elisa Greggio,Sabine Hilfiker,Laura Civiero +20 more
TL;DR: In this paper, the authors show that EAAT2 trafficking is impaired by the leucine-rich repeat kinase 2 (LRRK2) pathogenic variant G2019S, a common cause of late-onset familial Parkinson9s disease (PD).
LRRK2 kinase modulates glucose-stimulated insulin secretion via RAB8 phosphorylation and ciliogenesis
Nevia Dule,A. Marku,Alessandra Galli,Francesca Pischedda,Adriano Lama,Michela Castagna,Paola Marciani,Federico Bertuzzi,Giovanni Piccoli,Carla Perego +9 more
- 17 Jul 2025
TL;DR: LRRK2 kinase regulates glucose-stimulated insulin secretion by phosphorylating RAB8 and modulating ciliogenesis, influencing secretory granule trafficking and basal insulin release, with implications for Parkinson's disease development through peripheral action.